An Act to clarify prescription monitoring program activities
Senate: Bill reported favorably by committee and referred to the committee on Senate Rules
Email me when S 1479 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 1479. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The legislation amends the state’s prescription monitoring law to exclude testosterone from the list of drugs tracked by the system. It also requires the department to erase any current records of testosterone prescriptions and dispensings. This change affects healthcare providers, pharmacies, and patients who use testosterone.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 1479
3 free questions a day, no accountHearings
- Public Health hearing on legislation related to disease prevention, screening, and treatment, and pharmacies.Joint Committee on Public Health · Jun 11, 2025
History
- Bill reported favorably by committee and referred to the committee on Senate Rules
- Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
- Referred to the committee on Public Health
- House concurred
Sponsors
- William N. Brownsberger · sponsor
- Julian Cyr
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 1479 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 1479 freeOr ask your AI assistant about S 1479 directly:
Add to Claude, ChatGPT or Cursor